Interlinked Dawamandi Profile
Key Indicators
- Authorised Capital ₹ 8.00 Cr
as on 22-06-2024
- Paid Up Capital ₹ 7.67 Cr
as on 22-06-2024
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 Cr
as on 22-06-2024
- Satisfied Charges ₹ 5.00 M
as on 22-06-2024
- Revenue -4.84%
(FY 2023)
- Profit 34.60%
(FY 2023)
- Ebitda 92.87%
(FY 2023)
- Net Worth -54.88%
(FY 2023)
- Total Assets -29.92%
(FY 2023)
About Interlinked Dawamandi
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 7.67 Cr.
The company currently has active open charges totaling ₹3.00 Cr. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Varun Shrivastava, Chander Sharma, Raj Shekhar, and One other member serve as directors at the Company.
- CIN/LLPIN
U51909UP2018PTC102732
- Company No.
102732
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Apr 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Interlinked Dawamandi?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Varun Shrivastava  | Additional Director | 15-Jul-2023 | Current |
| Manish Saxena | Director | 03-Apr-2018 | Current |
| Chander Sharma | Director | 03-Apr-2018 | Current |
| Raj Shekhar | Additional Director | 15-Jul-2023 | Current |
Financial Performance of Interlinked Dawamandi.
Interlinked Dawamandi Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 4.84% decrease. The company also saw a substantial improvement in profitability, with a 34.6% increase in profit. The company's net worth observed a substantial decline by a decrease of 54.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Interlinked Dawamandi?
In 2023, Interlinked Dawamandi had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sysmedic Pharmaceuticals Private LimitedActive 11 months 30 daysVarun Shrivastava and Chander Sharma are mutual person
- Obmed Pharma Private LimitedActive 2 years 5 months
Varun Shrivastava and Raj Shekhar are mutual person
- Shreekantha Infrapromoters Private LimitedActive 10 years 8 months
Varun Shrivastava is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 17 Mar 2020 | ₹3.00 Cr | Open |
Canara Bank Creation Date: 09 Feb 2022 | ₹5.00 M | Satisfied |
How Many Employees Work at Interlinked Dawamandi?
Interlinked Dawamandi has a workforce of 4 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Interlinked Dawamandi, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Interlinked Dawamandi's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
